Evidencio

What Evidencio does

Evidencio BV is a Netherlands-based medical decision support company founded in 2015 that operates a cloud-based platform hosting 8,000+ medical prediction algorithms across 56+ clinical specialties. The platform enables researchers, clinicians, and independent software vendors (ISVs) to create, configure, publish, validate, share, and clinically deploy prediction algorithms, with native support for linear regression, logistic regression, Cox Proportional-Hazards regression, custom mathematical formulas, and R-Script execution. Evidencio holds ISO27001, NEN7510, and ISO13485 certifications and acts as a Legal Manufacturer for CE-marking Class IIa/IIb Software as a Medical Device (SaMD) under EU MDR, offering end-to-end pre-assessment, technical documentation, and notified-body certification services.

The company distributes through multiple channels: a self-serve web and mobile platform with a freemium model (Free for personal/academic use, Pro at €9.99/month for clinical/commercial use), a marketplace for CE-certified medical device algorithms, an algorithm embedding iframe, and a REST API supporting JSON, XML, HL7 FHIR, and CDS Hooks for integration into EHR systems. Confirmed EHR integrations include EPIC (via the EPIC Connection Hub), Cerner, HiX (Chipsoft), Nexus, and GE Healthcare. Additional revenue streams include content licensing commissions on third-party certified algorithms, professional services for algorithm development using machine learning and deep learning on anonymized data, and one-off pre-assessment and certification engagements priced from €10k plus VAT.

The company serves three primary segments: digital health application users (clinicians and care teams using certified medical-device algorithms), algorithm developers and IP owners seeking CE certification and a distribution channel, and ISVs embedding medical algorithms into proprietary software, apps, and websites via API. Evidencio BV is privately held with 1-10 employees, headquartered in Haaksbergen, the Netherlands, operates no disclosed subsidiaries or parent entities, has no recorded funding rounds, and operates on a subscription-based SaaS revenue model with no public revenue disclosure.

Name

Evidencio

Legal name

Evidencio BV

Website

https://evidencio.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Evidencio is a Netherlands-based medical decision support platform hosting 8,000+ clinical prediction algorithms across 56+ specialties. It certifies algorithms as CE-marked SaMD under EU MDR and distributes them via API and integrations with EPIC, Cerner, HiX, Nexus, and GE Healthcare.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

akta.pro secondary industry

Acute Care & Hospital EHRs (HLACAAAA)

Keywords

• Clinical decision support
• Medical prediction algorithms
• Software as medical device
• CE certification services
• EHR algorithm integration

Headquarters

HQ city

Haaksbergen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Revenue: Tiered subscription model with Free (personal/academic), Pro at €9.99/month (clinical/commercial use), and Enterprise (custom pricing). Subscriptions provide access to algorithm libraries, API usage rights, and platform features.
2. Medical Device Library Marketplace: Algorithm subscriptions for CE-certified medical devices purchased through the marketplace. Individual algorithms available from €X/month with departmental and institutional bundles. Evidencio takes a commission on third-party algorithm licensing revenue.
3. Professional Services: Algorithm development services using machine learning, deep learning, and AI on anonymized data. Includes algorithm discovery, development, validation, and publication support. Pricing for pre-assessment starts at €10k plus VAT.
4. Content Licensing: IP owners can license algorithms to Evidencio platform users. Evidencio acts as authorized distributor for third-party CE-certified algorithms, earning commission on license fees.
5. API Commercial Usage: Commercial API usage fees for embedding algorithms in proprietary software, apps, or websites. Custom pricing based on use case, volume, and integration requirements.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Evidencio operates a cloud-based medical decision support platform that hosts a library of 8,000+ medical prediction algorithms spanning 56+ specialties. The company enables clinical deployment of these algorithms as CE-certified Software as a Medical Device (SaMD/MDSW), provides CE-certification and legal manufacturing services under EU MDR, and exposes the algorithms via a REST API (HL7 FHIR, CDS Hooks) for integration with EHR systems such as EPIC, Cerner, HiX, Nexus, and GE Healthcare.

Product overview

Evidencio is a cloud-based medical decision support platform structured as a platform-plus-modules architecture. The core platform provides an Algorithm Library of 8,000+ medical prediction algorithms across 60+ specialties, which feeds into the Medical Device Library (Marketplace) for CE-certified clinical algorithms. The Evidencio API enables third-party integration with EHR systems including EPIC, HiX, Cerner, Nexus, and GE Healthcare via HL7 FHIR and CDS Hooks. Additional modules include Algorithm Development Services for custom algorithm creation, CE Certification & Legal Manufacturing Services for regulatory compliance, Algorithm Embedding for website integration, and mobile apps for iOS and Android. The Validation Tools module allows researchers to validate algorithms against their own data.

Differentiator

Problem solved

Functional benefit

Products and services

• Evidencio Medical Decision Support Platform Cloud-based SaaS platform enabling creation, validation, sharing, and clinical use of medical prediction algorithms as certified medical devices. Targeted at clinicians, researchers, algorithm developers, and healthcare organizations.
• Algorithm Library Digital library hosting 8,000+ medical prediction algorithms across 56+ medical specialties, allowing users to configure, publish, use, share, and validate algorithms.
• Medical Device Library (Marketplace) CE-certified medical device algorithm marketplace offering licensed subscriptions for clinical use, including Evidencio-manufactured and third-party licensed algorithms, with departmental and institutional bundles. Evidencio earns commission on third-party algorithm licensing revenue.
• Evidencio API REST API supporting JSON, XML, HL7 FHIR, and CDS Hooks that enables third-party software vendors, EHR systems, and ISVs to embed medical prediction algorithms into their applications, with authentication via unique security keys.
• Algorithm Development Services Professional services for algorithm discovery, development, and validation using machine learning, deep learning, and AI on anonymized data, including data preparation, algorithm conversion, and publishing guidance for healthcare organizations and IP owners.
• CE Certification & Legal Manufacturing Services Medical device certification services in which Evidencio acts as Legal Manufacturer for certifying medical algorithms as Class IIa/IIb CE-marked devices under EU MDR, including pre-assessment, technical documentation, risk assessment, and notified body coordination. Pre-assessment starts at €10k plus VAT.
• Evidencio Mobile App iOS and Android mobile applications providing access to medical prediction algorithms for clinical use on smartphones and tablets.

Quantifiable outcome

• Certification costs reduced by over 50% compared to self-certification
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• EPIC SystemscoreTechnology or IntegrationCE-certified Evidencio algorithms are listed and available in the EPIC Connection Hub, enabling direct integration into EPIC EHR systems. This integration allows clinicians like cardiologists to access Evidencio algorithms directly within their EPIC workflow for patient risk assessment.
• CernercoreTechnology or IntegrationEvidencio algorithms can be integrated into Cerner EHR systems, enabling healthcare providers using Cerner to access clinical decision support tools directly in their workflow.
• HiX (Chipsoft)coreTechnology or IntegrationIntegration partnership enabling Evidencio medical device algorithms to be accessed within HiX EHR systems used by healthcare organizations in the Netherlands.
• Nexus (Healthcare IT)coreTechnology or IntegrationEvidencio algorithms integrated with Nexus healthcare IT systems, providing clinical decision support capabilities to Nexus users.
• GE HealthcarecoreTechnology or IntegrationIntegration partnership enabling Evidencio algorithms to be accessed within GE Healthcare systems for clinical decision support.
• Foot Center WenderminorStrategic or Co-development PartnerCustom decision tree development partnership using Evidencio platform tools to create patient history support systems integrated into Foot Center Wender's existing healthcare system.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Viz.ai: AI-driven clinical decision support for time-sensitive conditions (e.g., stroke), with deep EHR integration and a CE-marked/FDA-cleared SaaMD posture similar to Evidencio's certified algorithm model.
• Aidoc: Provides AI-based clinical decision support for medical imaging, integrated into EHR workflows — a comparable point-of-care SaMD model with hospital distribution focus.
• DreaMed Diabetes: Develops CE-marked and FDA-cleared AI decision-support algorithms (e.g., insulin dosing) that operate as SaMD inside clinical workflows, comparable to Evidencio's CE-certified algorithm marketplace.

Broad incumbents

• Oracle Health (Cerner): Major EHR vendor with embedded decision support and AI initiatives — comparable distribution channel for Evidencio's algorithms but also a potential competitor if native CDS expands.
• Tempus Labs: Broader precision medicine and clinical decision support platform combining molecular data, AI models, and EHR integration — overlapping with Evidencio on algorithm-driven clinical insights at the point of care.
• Health Catalyst: Healthcare data and analytics platform with embedded decision support and AI modules — overlapping with Evidencio on data-driven CDS delivered into clinical workflows.
• Epic Systems: Dominant EHR vendor with a growing native CDS and ML capabilities, including the Connection Hub where Evidencio's algorithms are listed — represents both a channel partner and a competitive threat.
• Wolters Kluwer (UpToDate / ClinicalPath): Established clinical decision support vendor offering evidence-based guidance embedded in EHR workflows, competing with Evidencio for the same hospital CDS budget.
• Elsevier ClinicalPath: Enterprise clinical decision support and care pathway solutions embedded in major EHR systems — a comparable (and broader) incumbent targeting the same point-of-care decision support use case.

Direct peers

• SOPHiA GENETICS: Operates a clinical decision support platform that uses AI to analyze complex genomic and radiomic data, sharing the same SaaS-plus-CE-certified-algorithm model for hospitals and clinicians.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/evidencio_org

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evidencio